Cargando…
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
INTRODUCTION: The present analysis aims to evaluate the consequences of a 2-month interruption of mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments in a region of Northern Italy highly affected by the severe acute respiratory syndrome-related coronavirus-2 (SARS-...
Autores principales: | Toss, A., Isca, C., Venturelli, M., Nasso, C., Ficarra, G., Bellelli, V., Armocida, C., Barbieri, E., Cortesi, L., Moscetti, L., Piacentini, F., Omarini, C., Andreotti, A., Gambini, A., Battista, R., Dominici, M., Tazzioli, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878116/ https://www.ncbi.nlm.nih.gov/pubmed/33582382 http://dx.doi.org/10.1016/j.esmoop.2021.100055 |
Ejemplares similares
-
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials
por: Omarini, Claudia, et al.
Publicado: (2020) -
COVID-related disruption in mammographic screening: a year later
por: Toss, A., et al.
Publicado: (2022) -
Male mammary myofibroblastoma: Two case reports and brief review of literature
por: Venturelli, Marta, et al.
Publicado: (2020) -
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
por: Toss, Angela, et al.
Publicado: (2022) -
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe
por: Moscetti, L., et al.
Publicado: (2021)